A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
Clinical trial NCT00874939 · TERMINATED
Trial details
- NCT number
- NCT00874939
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-06
- Primary completion
- 2009-04-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.